Stockscreener 앱 받기
1.98
3.41%
-0.07
시간 외 거래:
2.01
0.03
+1.52%
전일 마감가:
$2.05
열려 있는:
$2.05
하루 거래량:
50,460
Relative Volume:
0.04
시가총액:
$24.35M
수익:
$22.06M
순이익/손실:
$-30.94M
주가수익비율:
-0.8839
EPS:
-2.24
순현금흐름:
$-26.70M
1주 성능:
+7.03%
1개월 성능:
-16.10%
6개월 성능:
+3.66%
1년 성능:
-66.33%
1일 변동 폭
$1.98
$2.13
1주일 범위
$1.7704
$2.13
52주 변동 폭
$1.0909
$6.50
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
CASI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
1.98 | 31.76M | 22.06M | -30.94M | -26.70M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-26 | 개시 | Mizuho | Buy |
| 2020-10-23 | 개시 | Oppenheimer | Outperform |
| 2016-09-22 | 개시 | Maxim Group | Buy |
| 2015-10-29 | 재개 | H.C. Wainwright | Buy |
| 2015-06-23 | 개시 | H.C. Wainwright | Buy |
모두보기
Casi Pharmaceuticals Inc 주식(CASI)의 최신 뉴스
CASI Pharmaceuticals Inc. stock momentum explained2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Trend analysis for CASI Pharmaceuticals Inc. this weekRisk Management & Daily Growth Stock Tips - newser.com
Sector ETF performance correlation with CASI Pharmaceuticals Inc.2025 Analyst Calls & Safe Entry Point Identification - newser.com
How sentiment analysis helps forecast CASI Pharmaceuticals Inc.Sell Signal & Precise Swing Trade Entry Alerts - newser.com
Backtesting results for CASI Pharmaceuticals Inc. trading strategiesJuly 2025 Action & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-10-09 04:50:23 - newser.com
Volume spikes in CASI Pharmaceuticals Inc. stock – what they meanJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
Can CASI Pharmaceuticals Inc. hit a new high this monthJuly 2025 PostEarnings & Weekly High Return Opportunities - newser.com
Head to Head Contrast: CASI Pharmaceuticals (NASDAQ:CASI) and Ardelyx (NASDAQ:ARDX) - Defense World
Evotec (NASDAQ:EVO) versus CASI Pharmaceuticals (NASDAQ:CASI) Critical Survey - Defense World
Does CASI Pharmaceuticals Inc. qualify in momentum factor screening2025 Analyst Calls & Growth Oriented Trading Recommendations - newser.com
Why CASI Pharmaceuticals Inc. stock remains undervaluedJuly 2025 Big Picture & High Return Stock Watch Alerts - newser.com
How to interpret RSI for CASI Pharmaceuticals Inc. stock2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Why CASI Pharmaceuticals Inc. is moving todayRate Hike & AI Powered Buy and Sell Recommendations - newser.com
Can CASI Pharmaceuticals Inc. stock attract ESG capital inflowsPortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
Is CASI Pharmaceuticals Inc. showing signs of accumulation2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Will CASI Pharmaceuticals Inc. stock maintain dividend yield2025 Price Targets & Safe Entry Momentum Stock Tips - newser.com
Order flow analysis tools used on CASI Pharmaceuticals Inc.2025 EndofYear Setup & Safe Entry Zone Tips - newser.com
Casi Pharmaceuticals appoints James Hunag to board of directors - MSN
Will CASI Pharmaceuticals Inc. benefit from macro trendsJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Intraday pattern recognizer results for CASI Pharmaceuticals Inc.2025 Market Sentiment & Fast Moving Trade Plans - newser.com
Little Excitement Around CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Revenues As Shares Take 43% Pounding - Sahm
What analysts say about CASI Pharmaceuticals Inc stockHigh Beta Stocks & Small Investment Capital Tips - earlytimes.in
Casi Pharmaceuticals Inc (CASI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):